Ordinary Rebalance | Solactive China Healthcare Disruption Index | Effective Date 1st June 2023
Solactive China Healthcare Disruption Index:
In the ordinary rebalance, effective open 01.06.2023 the following index composition was implemented:
| 3D MEDICINES INC | 1.427 % |
| 3SBIO INC | 1.4469 % |
| AKESO INC | 2.1987 % |
| ALIBABA HEALTH INFORMATION TECHNOLOGY LTD | 4.6996 % |
| ALPHAMAB ONCOLOGY | 0.5781 % |
| ANGELALIGN TECHNOLOGY INC | 0.9187 % |
| BEIJING CHUNLIZHENGDA MEDICAL INSTRUMENTS CO LTD | 0.8832 % |
| CANSINO BIOLOGICS INC | 0.8565 % |
| CHINA MEDICAL SYSTEM HOLDINGS LTD | 2.0204 % |
| CSPC PHARMACEUTICAL GROUP LTD | 6.0809 % |
| GENSCRIPT BIOTECH CORP | 2.7466 % |
| GIANT BIOGENE HOLDING CO LTD | 2.4447 % |
| GRAND PHARMACEUTICAL GROUP LTD | 1.3507 % |
| GUSHENGTANG HOLDINGS LTD | 0.8441 % |
| HANSOH PHARMACEUTICAL GROUP CO | 5.7601 % |
| INNOCARE PHARMA LTD | 1.0609 % |
| INNOVENT BIOLOGICS INC | 4.2224 % |
| JD HEALTH INTERNATIONAL INC | 8.3461 % |
| JOINN LABORATORIES CHINA C-H | 1.8248 % |
| KEYMED BIOSCIENCES INC | 0.8539 % |
| LIVZON PHARMACEUTICAL GROUP INC | 2.5364 % |
| LUYE PHARMA GROUP LTD | 0.9834 % |
| MICROPORT SCIENTIFIC CORP | 1.8504 % |
| NEW HORIZON HEALTH LTD | 0.9648 % |
| PING AN HEALTHCARE AND TECHNOL | 1.5136 % |
| REMEGEN CO LTD-H | 2.1638 % |
| SHANDONG WEIGAO GROUP MEDICAL POLYMER CO LTD | 3.9228 % |
| SHANGHAI FOSUN PHARMACEUTICAL GROUP CO LTD | 6.4 % |
| SHANGHAI JUNSHI BIOSCIENCES CO LTD | 3.4131 % |
| SHANGHAI MICROPORT MEDBOT GR | 1.3083 % |
| SIMCERE PHARMACEUTICAL GROUP | 1.5146 % |
| SINO BIOPHARMACEUTICAL LTD ORD | 5.2554 % |
| WUXI APPTEC CO LTD | 8.0362 % |
| WUXI BIOLOGICS CAYMAN INC | 7.6768 % |
| ZAI LAB LTD | 1.8959 % |